- Home
- ASRT vs HBIO Comparison
ASRT vs HBIO Comparison
Compare ASRT & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- HBIO
- Stock Information
- Founded
- ASRT 1995
- HBIO 1901
- Country
- ASRT United States
- HBIO United States
- Employees
- ASRT 30
- HBIO N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ASRT Health Care
- HBIO Industrials
- Exchange
- ASRT Nasdaq
- HBIO Nasdaq
- Market Cap
- ASRT 84.6M
- HBIO 93.3M
- IPO Year
- ASRT 1997
- HBIO 2000
- Fundamental
- Price
- ASRT $0.89
- HBIO $2.11
- Analyst Decision
- ASRT Strong Buy
- HBIO
- Analyst Count
- ASRT 4
- HBIO 0
- Target Price
- ASRT $3.19
- HBIO N/A
- AVG Volume (30 Days)
- ASRT 912.6K
- HBIO 164.0K
- Earning Date
- ASRT 11-11-2024
- HBIO 11-07-2024
- Dividend Yield
- ASRT N/A
- HBIO N/A
- EPS Growth
- ASRT N/A
- HBIO N/A
- EPS
- ASRT N/A
- HBIO N/A
- Revenue
- ASRT $125,763,000.00
- HBIO $97,732,000.00
- Revenue This Year
- ASRT N/A
- HBIO N/A
- Revenue Next Year
- ASRT $1.84
- HBIO $4.32
- P/E Ratio
- ASRT N/A
- HBIO N/A
- Revenue Growth
- ASRT N/A
- HBIO N/A
- 52 Week Low
- ASRT $0.73
- HBIO $1.99
- 52 Week High
- ASRT $1.80
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- ASRT 42.24
- HBIO 43.18
- Support Level
- ASRT $0.90
- HBIO $2.01
- Resistance Level
- ASRT $1.04
- HBIO $2.23
- Average True Range (ATR)
- ASRT 0.07
- HBIO 0.13
- MACD
- ASRT -0.01
- HBIO -0.01
- Stochastic Oscillator
- ASRT 28.11
- HBIO 27.03
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.